Journal of Cancer Research and Therapeutics Close
 

Figure 5: Effects of curcumin-loaded nanostructured lipid carriers on the production of vascular endothelial growth factor receptor 1 and 2 (VEGFR-1 and VEGFR-2) in HepG2 cells. (a) Western analysis of VEGFR-1 and VEGFR-2 in HepG2 cells. (b) Bar graphs show quantitative evaluation of VEGFR-1 and VEGFR-2 bands by densitometry from triplicate independent experiments. Equal amounts from sample were analyzed with specific antibodies for VEGFR-1 and VEGFR-2 and β-actin. *P < 0.05, **P < 0.01 compared with control group (n = 3, mean ± standard deviation)

Figure 5: Effects of curcumin-loaded nanostructured lipid carriers on the production of vascular endothelial growth factor receptor 1 and 2 (VEGFR-1 and VEGFR-2) in HepG2 cells. (a) Western analysis of VEGFR-1 and VEGFR-2 in HepG2 cells. (b) Bar graphs show quantitative evaluation of VEGFR-1 and VEGFR-2 bands by densitometry from triplicate independent experiments. Equal amounts from sample were analyzed with specific antibodies for VEGFR-1 and VEGFR-2 and β-actin. *<i>P</i> < 0.05, **<i>P</i> < 0.01 compared with control group (<i>n</i> = 3, mean ± standard deviation)